PATENT CLAIM ANALYSIS

Application Number: 16013071
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "367000"]

Abstract:
Disclosed herein are methods of treating conditions, which may be associated with elevated levels of plasma cells and/or B-cells, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.

Claim (Index 59):
The method of  claim 46 , wherein administering comprises administering about 75 mg two times per day.

Metadata:
- Claim Count in Document: 107.0
- Percentile: 94.0
- Lexical Diversity: 1.13333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15461131', '14912015', '15675912', '15889714', '14912058']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8104337049369484
- 35 USC 102 Novelty (BERT): 0.6133252710939319
- Combined Prediction Score: 0.7907228615526468
- Mean Citation Score: 503.378368
- Max Citation Score: 531.966
- Similarity Product: 507.5537772059441

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test